PubMed Health⌕ Search

Biomedical subjects

Heng Xu

Publications and source records attributed to Heng Xu.

33 records · Page 2Linked to original sources

Reversible chemistry of CO2 in the preparation of fluorescent supramolecular polymers.

The chemistry between CO(2) and primary amines was used to construct novel types of supramolecular polymers and networks. Fluorescent self-assembling gel 2 was prepared, which employs both hydrogen bonding and dynamic, thermally reversible carbamate bonds. As precursors, biscalixarenes 1, 3, 4, 6, and 7 were synthesized, which strongly aggregate (K(D) > or = 10(6) M(-1) per capsule) in apolar solution with the formation of linear self-assembling polymers. Polymer 1n possesses CO(2)-philic primary amino groups on the periphery. CO(2) rapidly reacts with chains 1n in apolar solvents and cross-links them with the formation of multiple carbamate salt bridges. Three-dimensional polymeric network 2 was characterized by (13)C NMR spectroscopy and SEM. Addition of competitive solvent breaks hydrogen bonding in 2 but does not influence the carbamate linkers. Carbamate salt 9 was obtained. On the other hand, thermal release of CO(2) from 2 and 9 was easily accomplished (1 h, 100 degrees C) with retaining the hydrogen-bonding capsules. Thus, three-dimensional polymeric networks 2 were transformed back to linear polymeric chains 1n without their breakup. Multiple pyrene fluorophores, attached on the periphery of 2, cause strong fluorescence of the gel with benzene. When approximately 5% nitrobenzene was gelated together with benzene, fluorescence strongly decreases due to the energy transfer from the pyrene donors in gel 2 to trapped nitrobenzene molecules. This opens a way to switchable fluorescent materials.

Amines↗

CO2 in supramolecular chemistry: preparation of switchable supramolecular polymers.

CO2 gas was used to construct novel types of supramolecular polymers. Self-assembling nanostructures 11 and 13 were prepared, which employ both hydrogen bonding and dynamic, thermally reversible carbamate bonds. As precursors, calixarene ureas 1 and 2 were synthesized, which strongly aggregate/dimerize (K(D)>/=10(6) M(-1) per capsule) in apolar solution with the formation of self-assembling capsules 7 and linear polymeric chains 8, respectively, and also possess "CO2-philic" primary amino groups on the periphery. CO2 effectively reacts with molecules 7 and 8 in apolar solvents and cross-links them with the formation of multiple carbamate salt bridges. Oligomeric aggregate 11 and three-dimensional polymeric network 13 were prepared and characterized by 1H and 13C NMR spectroscopy. The morphology of supramolecular gel 13 was studied by scanning electron microscopy. Addition of a competitive solvent destroyed the hydrogen bonding in assembling structures 11 and 13, but did not influence the carbamate linkers; carbamate salts 12 and 14, respectively, were obtained. On the other hand, thermal release of CO2 from 11 and 13 was easily accomplished (1 h, 100 degrees C) while retaining the hydrogen-bonding capsules. Thus, three-dimensional polymeric network 13 was transformed back to linear polymeric chain 8 without breaking up. Encapsulation and storage of solvent molecules by 11 and 13 was demonstrated. This opens the way for switchable materials, which reversibly trap, store, and then release guest molecules. A two-parameter switch and control over hydrogen bonding and CO2-amine adducts was established.

Journal Article↗

3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.

UNLABELLED: Previous experiments conducted in this laboratory showed that administration of high-dose D-fenfluramine (D-FEN) and p-chloroamphetamine (PCA) decreased 5-HT transporter (SERT) binding and tissue 5-HT by 30-60% in caudate and whole brain tissue 2 days and 2 weeks after drug administration. However, protein expression as determined by Western blot analysis did not change in either tissue or time point, except for a 30% decrease in the caudate 2 days after PCA administration. In the present study, we studied the effect of MDMA and 5,7-dihydroxytryptamine (5,7-DHT) on tissue 5-HT levels and the protein expression level of SERT and glial fibrillary acidic protein (GFAP), a validated neurotoxicity marker. HYPOTHESIS: MDMA administration decreases SERT expression. METHODS: Two weeks after MDMA administration (7.5 mg/kg i.p., q 2 h x 3 doses) or 2 weeks after i.c.v. administration of 5,7,-DHT (150 microg/rat), male Sprague-Dawley rats were sacrificed and the caudate, cortex, and hippocampal tissue collected. Western blots for SERT and GFAP were generated using published methods. Tissue 5-HT levels were determined by HPLC coupled to electrochemical detection. RESULTS: MDMA treatment decreased tissue 5-HT in cortex, hippocampus, and caudate by about 50%. However, MDMA treatment had no significant effect on expression level of SERT and GFAP in any brain region. In contrast, 5,7-DHT reduced tissue 5-HT by more than 90%, decreased SERT protein expression by 20-35%, and increased GFAP by 30-39%. CONCLUSION: These data suggest the MDMA treatment regimen used here does not cause degeneration of 5-HT nerve terminals. Viewed collectively with our previous results and other published data, these data indicate that MDMA-induced persistent 5-HT depletion may occur in the absence of axotomy.

3,4-Dihydroxyphenylacetic Acid↗

Absorption and scattering imaging of tissue with steady-state second-differential spectral-analysis tomography.

A novel approach to reconstructing both the absorption and the scattering properties of a turbid medium simultaneously from steady-state broadband spectral measurements is presented that utilizes second-differential fitting to the water spectrum to estimate the optical path length in tissue. Theoretical and experimental evidence is provided to demonstrate the robust accuracy of the spectroscopy approach and reconstructed absorption images. The steady-state broadband CCD system has the potential to provide accurate chromophore imaging without the technological complexity of time- or frequency-domain systems.

Absorption↗

Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.

RGS proteins are a recently described class of regulators that influence G-protein-mediated signaling pathways. We have shown previously that chronic morphine results in functional uncoupling of the mu opioid receptor from its G protein in CHO cells expressing cloned human mu opioid receptors. In the present study, we examined the effects of morphine treatment (1 microM, 20 h) on DAMGO-stimulated high-affinity [35S]GTP-gamma-S binding and DAMGO-mediated inhibition of forskolin-stimulated cAMP accumulation in HN9.10 cells stably expressing the cloned rat mu opioid receptor, in the absence and presence of the RGS9 protein knock-down condition (confirmed by Western blot analysis). RGS9 protein expression was reduced by blocking its mRNA with an antisense oligodeoxynucleotide (AS-114). Binding surface analysis resolved two [35S]GTP-gamma-S binding sites (high affinity and low affinity sites). In sense-treated control cells, DAMGO-stimulated [35S]GTP-gamma-S binding by increasing the B(max) of the high-affinity site. In sense-treated morphine-treated cells, DAMGO-stimulated [35S]GTP-gamma-S binding by decreasing the high-affinity Kd without changing the B(max). AS-114 significantly inhibited chronic morphine-induced upregulation of adenylate cyclase activity and partially reversed chronic morphine effects as measured by DAMGO-stimulated [35S]GTP-gamma-S binding. Morphine treatment increased the EC50 (6.2-fold) for DAMGO-mediated inhibition of forskolin-stimulated cAMP activity in control cells but not in cells treated with AS-114 to knock-down RGS9. These results provide additional evidence for involvement of RGS9 protein in modulating opioid signaling, which may contribute to the development of morphine tolerance and dependence.

Adenylyl Cyclases↗

[Quality evaluation of prepared slices of Paeonia lactiflon--determination of paeoniflorin by HPLC].

OBJECTIVE: To establish the quality criteria of the prepared slices of Paeonia lactiflon. METHOD: RP-HPLC was used for the determination of paeoniflorin in 10 lots of samples by ultrasound-assisted extraction. RESULT: The samples were extracted with 50% methanol. Seperation of the solution was performed on an ODS column with a mobile phase of acetonitrile-water (18:82), detected at 230 nm. CONCLUSION: The method is simple, repeatable, accurate and applicable.

Benzoates↗

A pH switch in supramolecular polymeric capsules.

[structure: see text] A switchable, supramolecular polymer is introduced which is held together through hydrogen bonding and reversibly precipitates-redissolves upon subtle pH control. Precipitating, it entraps and stores guest molecules within the self-assembling capsules incorporated within the polymeric chain.

Journal Article↗

Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.

(3R)-7-Hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) was identified as a potent and selective kappa opioid receptor antagonist. Structure-activity relationship (SAR) studies on JDTic analogues revealed that the 3R,4R stereochemistry of the 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine core structure, the 3R attachment of the 7-hydroxy-1,2,3,4-tetrahydroisoquinoline group, and the 1S configuration of the 2-methylpropyl (isopropyl) group were all important to its kappa potency and selectivity. The results suggest that, like other kappa opioid antagonists such as nor-BNI and GNTI, JDTic requires a second basic amino group to express potent and selective kappa antagonist activity in the [(35)S]GTPgammaS functional assay. However, unlike previously reported kappa antagonists, JDTic also requires a second phenol group in rigid proximity to this second basic amino group. The potent and selective kappa antagonist properties of JDTic can be rationalized using the "message-address" concept wherein the (3R,4R)-3,4-dimethyl-4-(hydroxyphenyl)piperidinyl group represents the message, and the basic amino and phenol group in the N substituent constitutes the address. It is interesting to note the structural commonality (an amino and phenol groups) in both the message and address components of JDTic. The unique structural features of JDTic will make this compound highly useful in further characterization of the kappa receptor.

Animals↗

Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.

Chronic morphine treatment results in functional uncoupling of the mu opioid receptor and its G protein in both cell culture and animal models. In the present study, Chinese hamster ovary (CHO) cells stably expressing the cloned human mu opioid receptor (hMOR-CHO cells) were incubated with 1 microM of morphine (or no drug) for 20 h. Subsequently, we assessed DAMGO- and morphine-stimulated [(35)S]-GTP-gamma-S binding and agonist-mediated inhibition of forskolin-stimulated cAMP accumulation. Using a single concentration of [(35)S]-GTP-gamma-S (0.05 nM), chronic morphine treatment did not significantly change basal [(35)S]-GTP-gamma-S binding, shifted the morphine EC(50) from 59 nM to 146 nM, and decreased the maximal stimulation (E(max)) from 201% to 177%. Similar results were observed with DAMGO. Binding surface analysis resolved two [(35)S]-GTP-gamma-S binding sites (high-affinity and low-affinity sites). In control cells, morphine stimulated [(35)S]-GTP-gamma-S binding by increasing the B(max) of the high-affinity site. In morphine-treated cells, morphine stimulated [(35)S]-GTP-gamma-S binding by decreasing the high-affinity K(d) without changing the B(max). Morphine treatment increased the EC(50) (5-11-fold) for agonist-mediated inhibition of forskolin-stimulated cAMP accumulation. These changes were not observed in cells expressing a mutant mu opioid receptor which does not develop morphine tolerance, suggesting that the changes in [(35)S]-GTP-gamma-S binding observed in hMOR-CHO cells result from the development of morphine tolerance.

Adenylyl Cyclases↗

Endogenous CART peptide regulates mu opioid and serotonin 5-HT(2A) receptors.

Previous experiments conducted in this laboratory showed that intracerebroventricular (i.c.v.) administration of IgG antibodies directed against selected neuropeptides changed the density of CNS receptors, suggesting that neuropeptides in the cerebrospinal fluid can perform a regulatory role. To further test this hypothesis, we administered anti-CART peptide (the peptide product of cocaine amphetamine related transcript) IgG to rats via the i.c.v. route, and measured the density of opioid mu and delta receptors, beta-adrenergic and alpha(2)-adrenergic receptors and serotonin 5-HT(2A) receptors using ligand binding methods. We also used Western blots to determine the expression level of the mu, delta and 5-HT(2A) receptors. The results demonstrated that anti-CART peptide IgG up-regulates mu and 5-HT(2A) receptor in the hippocampus and caudate We conclude that CART peptides in the cerebrospinal fluid may exert regulatory effects in the brain.

Animals↗

Near-infrared imaging in the small animal brain: optimization of fiber positions.

We investigate fiber placement issues associated with a hybrid magnetic resonance imaging (MRI) near-infrared (NIR) imaging technique for small animal brain studies. Location of the optical fibers on the cranium is examined, with an emphasis on maximizing the recovered resolution and contrast in the region of interest, which in this case is the murine brain. In a series of simulation studies, singular value decomposition of the Jacobian is used in order to determine the measurement sites that provide the most information about the region of interest. The modeling results indicate that data collected using fibers arranged on one side of the head near the brain contain as much information about optical changes within the brain as those positioned equally spaced around the entire periphery of the head. Practical space limitation considerations favor the one-sided fiber array geometry in the case where the NIR acquisition is expected to occur simultaneously with MRI.

Animals↗

Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphans.

A library of compounds biased toward opioid receptor antagonist activity was prepared by incorporating N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphans as the core scaffold using simultaneous solution phase synthetic methodology. From this library, N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)-7alpha-[3-(1-piperidinyl)propanamido]morphan [(-)-3b] was identified as the first potent and selective kappa opioid receptor antagonist from the 5-phenylmorphan class of opioids.

Animals↗

Endogenous corticotropin releasing factor regulates adrenergic and opioid receptors.

Previous work from this laboratory demonstrated that intracerebroventricular (i.c.v.) administration of IgG antibodies directed against selected neuropeptides changed the density of opioid receptors, suggesting that neuropeptides in the CNS can perform a regulatory role. To further test this hypothesis, we administered anticorticotropin (CRF) IgG to rats via the i.c.v. route and measured the density of opioid mu and delta receptors and also beta- and alpha(2)-adrenergic receptors. The results demonstrated that anti-CRF IgG upregulates mu and beta-adrenergic receptors. We conclude that CRF in the cerebrospinal fluid may exert regulatory effects throughout the brain.

Animals↗

[Research on the synthesis and spectroscopy of the copolymer of polyvinyl alcohol and amino acid].

In this paper, a series of new polymers with grafted amino acids were synthesized. The purpose of the research is to develop a kind of polymer drugs with grafted amino acids for the treatment of some patients. The preparations of polyvinyl alcohol and amino acid were described by using inorganic acid as catalyst. The reaction methods were investigated in order to find the optimal conditions for the highest yield and purity. The copolymers were analysed and characterized by IR and 1HNMR. The result indicated that the reaction products were what we needed and the yield of the polymer of polyvinyl alcohol and glycine was higher than that of polyvinyl alcohol and alanine.

Alanine↗